Connection

Shikhar Mehrotra to Humans

This is a "connection" page, showing publications Shikhar Mehrotra has written about Humans.
Connection Strength

0.672
  1. Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function. Cancer Res. 2022 05 16; 82(10):1969-1990.
    View in: PubMed
    Score: 0.032
  2. New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy. Cells. 2022 02 17; 11(4).
    View in: PubMed
    Score: 0.031
  3. CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE. Trends Immunol. 2020 03; 41(3):187-189.
    View in: PubMed
    Score: 0.027
  4. CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
    View in: PubMed
    Score: 0.026
  5. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
    View in: PubMed
    Score: 0.025
  6. Replenishing Regulatory T Cells to Halt?Depigmentation in Vitiligo. J Investig Dermatol Symp Proc. 2017 10; 18(2):S38-S45.
    View in: PubMed
    Score: 0.023
  7. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
    View in: PubMed
    Score: 0.022
  8. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control. Oncotarget. 2016 Oct 25; 7(43):69371-69383.
    View in: PubMed
    Score: 0.021
  9. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240.
    View in: PubMed
    Score: 0.021
  10. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
    View in: PubMed
    Score: 0.018
  11. Promoting thiol expression increases the durability of antitumor T-cell functions. Cancer Res. 2014 Nov 01; 74(21):6036-6047.
    View in: PubMed
    Score: 0.018
  12. Interferon-gamma (IFN-?)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse. PLoS One. 2014; 9(2):e89392.
    View in: PubMed
    Score: 0.018
  13. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014 May; 134(5):1285-1294.
    View in: PubMed
    Score: 0.018
  14. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 2013 Apr 20; 18(12):1497-534.
    View in: PubMed
    Score: 0.016
  15. A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol. 2012 Aug 15; 189(4):1627-38.
    View in: PubMed
    Score: 0.016
  16. Dietary agents in cancer prevention: an immunological perspective. Photochem Photobiol. 2012 Sep-Oct; 88(5):1083-98.
    View in: PubMed
    Score: 0.016
  17. T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine. 2011 Aug; 55(2):307-17.
    View in: PubMed
    Score: 0.015
  18. Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death. Cancer Res. 2009 Aug 01; 69(15):6282-9.
    View in: PubMed
    Score: 0.013
  19. Oxidative stress and lymphocyte persistence: implications in immunotherapy. Adv Cancer Res. 2009; 102:197-227.
    View in: PubMed
    Score: 0.012
  20. Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death. J Leukoc Biol. 2007 Feb; 81(2):539-47.
    View in: PubMed
    Score: 0.011
  21. Macrophages as stimulators of MART-1 27-35 epitope-specific human cytolytic T lymphocytes in vitro. Pathobiology. 2006; 73(5):238-43.
    View in: PubMed
    Score: 0.010
  22. Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Immunology. 2004 Dec; 113(4):472-81.
    View in: PubMed
    Score: 0.009
  23. Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy. J Immunol. 2004 Nov 15; 173(10):6017-24.
    View in: PubMed
    Score: 0.009
  24. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res. 2003 Sep 01; 63(17):5607-14.
    View in: PubMed
    Score: 0.009
  25. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep. 2022 12 06; 41(10):111742.
    View in: PubMed
    Score: 0.008
  26. The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation. 2022 Oct 08; 19(1):251.
    View in: PubMed
    Score: 0.008
  27. S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission. Cell Mol Immunol. 2022 Nov; 19(11):1235-1250.
    View in: PubMed
    Score: 0.008
  28. Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells. Cancer Res. 2022 07 18; 82(14):2640-2655.
    View in: PubMed
    Score: 0.008
  29. HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
    View in: PubMed
    Score: 0.008
  30. Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. Leukemia. 2022 07; 36(7):1907-1915.
    View in: PubMed
    Score: 0.008
  31. Eosinophils and melanoma: Implications for immunotherapy. Pigment Cell Melanoma Res. 2022 03; 35(2):192-202.
    View in: PubMed
    Score: 0.008
  32. Hematopoietic stem cell-derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta. Stem Cells. 2021 11; 39(11):1457-1477.
    View in: PubMed
    Score: 0.007
  33. Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients. Sci Rep. 2021 07 09; 11(1):14232.
    View in: PubMed
    Score: 0.007
  34. Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T?cell response. Cell Rep. 2021 05 04; 35(5):109076.
    View in: PubMed
    Score: 0.007
  35. Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies. Clin Chem. 2020 12 01; 66(12):1531-1537.
    View in: PubMed
    Score: 0.007
  36. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Front Immunol. 2020; 11:581433.
    View in: PubMed
    Score: 0.007
  37. Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma. Free Radic Biol Med. 2020 11 20; 160:755-767.
    View in: PubMed
    Score: 0.007
  38. Histone Deacetylases Regulation by d-Opioids in Human Optic Nerve Head Astrocytes. Invest Ophthalmol Vis Sci. 2020 09 01; 61(11):17.
    View in: PubMed
    Score: 0.007
  39. CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020 07 17; 9(7).
    View in: PubMed
    Score: 0.007
  40. Identification of human CD4+ T cell populations with distinct antitumor activity. Sci Adv. 2020 07; 6(27).
    View in: PubMed
    Score: 0.007
  41. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. Immunity. 2020 04 14; 52(4):668-682.e7.
    View in: PubMed
    Score: 0.007
  42. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
    View in: PubMed
    Score: 0.007
  43. Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease. J Clin Invest. 2019 05 02; 129(7):2760-2774.
    View in: PubMed
    Score: 0.006
  44. ER stress-induced mediator C/EBP homologous protein thwarts effector T?cell activity in tumors through T-bet repression. Nat Commun. 2019 03 20; 10(1):1280.
    View in: PubMed
    Score: 0.006
  45. Mesenchymal Stem Cells from Chronic Pancreatitis Patients Show Comparable Potency Compared to Cells from Healthy Donors. Stem Cells Transl Med. 2019 05; 8(5):418-429.
    View in: PubMed
    Score: 0.006
  46. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies. Front Immunol. 2018; 9:1740.
    View in: PubMed
    Score: 0.006
  47. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.006
  48. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.
    View in: PubMed
    Score: 0.006
  49. Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death. Cancer Res. 2016 10 15; 76(20):6006-6016.
    View in: PubMed
    Score: 0.005
  50. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016 11 01; 76(21):6230-6240.
    View in: PubMed
    Score: 0.005
  51. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent. Cancer Immunol Res. 2015 Dec; 3(12):1364-74.
    View in: PubMed
    Score: 0.005
  52. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7.
    View in: PubMed
    Score: 0.005
  53. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother. 2015 May; 64(5):539-49.
    View in: PubMed
    Score: 0.005
  54. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun; 135(6):1574-1580.
    View in: PubMed
    Score: 0.005
  55. Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing. Oncogene. 2015 Jul; 34(28):3728-36.
    View in: PubMed
    Score: 0.005
  56. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014 Nov; 27(6):1075-85.
    View in: PubMed
    Score: 0.005
  57. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27; 5(174):174ra28.
    View in: PubMed
    Score: 0.004
  58. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol Med. 2012 Aug; 4(8):761-75.
    View in: PubMed
    Score: 0.004
  59. Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma. Clin Dermatol. 2009 Nov-Dec; 27(6):603-13.
    View in: PubMed
    Score: 0.003
  60. CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. J Immunol. 2008 Jul 15; 181(2):1063-70.
    View in: PubMed
    Score: 0.003
  61. Activation-induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis-inducing factor. Eur J Immunol. 2006 Dec; 36(12):3167-74.
    View in: PubMed
    Score: 0.003
  62. Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro. J Immunol. 2006 Jan 15; 176(2):984-90.
    View in: PubMed
    Score: 0.003
  63. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation. Eur J Immunol. 2004 Oct; 34(10):2824-33.
    View in: PubMed
    Score: 0.002
  64. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum Immunol. 2004 Aug; 65(8):794-802.
    View in: PubMed
    Score: 0.002
  65. Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation. Cancer Immunol Immunother. 2003 Aug; 52(8):497-505.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.